Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02778867 · ClinicalTrials.gov registry record · Phase 2
SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study
A Phase 2 study of Eosinophilic Esophagitis (EoE) and Eosinophilic Gastrointestinal Disorders (EGIDs), sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 2
- Development phase
- 129
- Enrollment target
- 9
- Study locations
NCT02778867 is a Phase 2 study of Eosinophilic Esophagitis (EoE) and Eosinophilic Gastrointestinal Disorders (EGIDs) that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 129 participants, above the 113-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (14% higher). The trial reports 9 study locations across 9 states.
The verdict
NCT02778867, a Phase 2 study of Eosinophilic Esophagitis (EoE) and Eosinophilic Gastrointestinal Disorders (EGIDs), has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 129 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this interventional study is to test and compare the effectiveness of two elimination diets-the 1-food elimination diet (1FED, milk only) and the 6-food elimination diet (6FED, milk, egg, wheat, soy, tree nut/peanuts, and fish/shellfish). The study will also test the effectiveness of swallowed glucocorticoid therapy in some of the study participants for whom diet therapy was not effective.
Conditions Studied
Interventions
- OTHER 1 Food Elimination Diet Therapy
- OTHER 6 Food Elimination Diet Therapy
- OTHER 6 Food Elimination Diet (after 1FED failure)
- DRUG Fluticasone Propionate, 880 mcg twice daily (after 6FED failure)
Study Locations (9)
California
- University of California, San Diego - La Jolla
Illinois
- Northwestern University - Chicago
Massachusetts
- Tufts University - Boston
Minnesota
- Mayo Clinic - Rochester
New York
- Icahn School of Medicine at Mount Sinai - New York
North Carolina
- University of North Carolina, Chapel Hill - Chapel Hill
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2016-05-20 |
| Est. Completion | 2019-05-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02778867
The ClinicalTrials.gov registry entry for NCT02778867 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 113-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (14% higher). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Eosinophilic Esophagitis (EoE) appearing as the primary indexed condition, and to 4 interventions - of which 1 Food Elimination Diet Therapy is the first listed.
NCT02778867 reports 9 study locations spanning 9 distinct geographic areas - top geographies include California, Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02778867 about?
NCT02778867 is a clinical study titled "SOFEED: Six Food vs. One Food Eosinophilic Esophagitis Diet Study". The purpose of this interventional study is to test and compare the effectiveness of two elimination diets-the 1-food elimination diet (1FED, milk only) and the 6-food elimination diet (6FED, milk, egg, wheat, soy, tree nut/peanuts, and fish/shellfish). The study will also test the effectiveness of ...
What is the current status of trial NCT02778867?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 129 participants. The study started on 2016-05-20. Estimated completion is 2019-05-29.
What conditions does trial NCT02778867 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis (EoE), Eosinophilic Gastrointestinal Disorders (EGIDs).
What interventions are being tested in trial NCT02778867?
The interventions under investigation include: 1 Food Elimination Diet Therapy (OTHER), 6 Food Elimination Diet Therapy (OTHER), 6 Food Elimination Diet (after 1FED failure) (OTHER), Fluticasone Propionate, 880 mcg twice daily (after 6FED failure) (DRUG).
Who is sponsoring clinical trial NCT02778867?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02778867 being conducted?
This trial has 9 study locations across California, Illinois, Massachusetts, Minnesota, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis (EoE)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
ACTIVE NOT RECRUITING · Phase 2
-
OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label Extension
COMPLETED · Phase 2
-
Surface EMG Testing on Swallowing in EoE Patients
RECRUITING
-
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
RECRUITING
-
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
RECRUITING · Phase 4
-
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
RECRUITING · Phase 3
Explore more on PlainTrial
Eosinophilic Esophagitis (EoE)
All registered trials for this condition
Eosinophilic Gastrointestinal Disorders (EGIDs)
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.